PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions
ANDERNACH, Germany , April 29, 2026 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today ...
2026-04-29T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical Equipment 
ESG | HitGen Releases 2025 Sustainability Report
CHENGDU, China , April 29, 2026 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) released its  2025 Sustainability Report on April 29, 2026. ...
2026-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
SHANGHAI , April 29, 2026 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY ...
2026-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results
JILIN, China , April 29, 2026 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, ...
2026-04-29T    Biotechnology   Health Care/Hospital 
Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
MUMBAI, India , April 29, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated ...
2026-04-29T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
ACROBiosystems Wins CiteAb Award, Gaining Worldwide Recognition
SAN DIEGO and NEWARK, Del. , April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as a "Protein Supplier to Watch in Cancer Research in 2026" at the CiteAb Awards. ...
2026-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Natural Field Releases Research Findings on NFTriSolve® Co-Loading Liposome Formula
XI'AN, China , April 28, 2026 /PRNewswire/ -- Natural Field announced that the latest research and development breakthrough of the NFTriSolve® co-loading liposome technology has been achieved. ...
2026-04-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
SHANGHAI , April 28, 2026 /PRNewswire/ -- On 28 April, Fosun Pharma  ("the Company", stock code: 600196.SH; 02196.HK) announced its results for the first quarter of 2026 (the reporting ...
2026-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ACROBiosystems Showcases AI-Driven Innovation at AACR 2026, Empowering Next-Generation Biologics Discovery
SAN DIEGO and NEWARK, N.J. , April 28, 2026 /PRNewswire/ -- From April 17 to 22, 2026, ACROBiosystems—a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries—presented ...
2026-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
C-Ray Therapeutics Receives FDA Acceptance of Type II Drug Master File for Copper-64 (Cu-64)
DMF No. 43568 is now active and available for reference in global IND and NDA submissions ...
2026-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.